Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
200
NCT00135460
Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients
Phase: Phase 4
Role: Lead Sponsor
Start: Jun 30, 2003
Completion: Nov 30, 2007
NCT00139178
Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.
Start: Mar 31, 2004
Completion: Apr 30, 2007